ALL
《Commercial Times》AmCad and Swiss Hospital Reveal Promising New Tech for OSA Treatment Success
《Commercial Times》AmCad and Swiss Hospital Reveal Promising New Tech for OSA Treatment Success
《Economic Daily News》AmCad & Stanford Sleep Center's research results published in "Sleep Medicine"
《Economic Daily News》AmCad & Stanford Sleep Center's research results published in "Sleep Medicine"
《Business Times》AmCad and Swiss Doctor presented study results at ISSS 2024
ISSS Annual Meeting 2024
《Economic Daily News》AmCad BioMed has been awarded the first EU MDR intelligent medical device software certification in Taiwan
AmCad BioMed - the first EU MDR intelligent medical device software certified company in Taiwan
《TAIPEI TIMES》NTUH uses AI to identify sleep apnea
National Taiwan University Hospital (NTUH) has developed an ultrasound device that uses artificial intelligence (AI) to assess in about 15 minutes a person’s risk of sleep apnea.
Revolutionary Diagnosis of Obstructive Sleep Apnea (OSA)
Revolutionary Diagnosis of Obstructive Sleep Apnea (OSA)
Tired all the time? Causes and When to see a doctor
AmCad-UO® using AI algorithm can help detect OSA faster in about 10 mins and in a non-invasive manner.
Thyroid ultrasound AI saves a woman’s life
AmCad-UT® powered with AI deep learning has made thyroid ultrasounds examination faster and easier.
Arab Health. Роботическая ультразвуковая система для диагностики апноэ сна
Arab Health. Роботическая ультразвуковая система для диагностики апноэ сна
are the trademarks owned by AmCad in Taiwan and/or in other countries. Unauthorized use of the AmCAD trademarks is prohibited unless specifically authorized.